 The Covid-19 pandemic has disrupted global public health and access to reproductive and child health services, particularly affecting women and children, with limited data on the impact on pregnant women and newborns. A gendered approach should be implemented in the development of Covid-19 vaccines, including the inclusion of pregnant and lactating mothers in clinical trials to address gender-based biological differences. This article was authored by Kranti Suresh Vora, Arthi Sundra Rajan, Shaheen Syed and others.